EAM
INZY
Eventide Asset Management’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,220,000
| Closed | -$6.15M | – | 239 |
|
|
2024
Q4 | $6.15M | Sell |
2,220,000
-1,914,436
| -46% | -$5.3M | 0.11% | 149 |
|
|
2024
Q3 | $21.6M | Buy |
4,134,436
+198,216
| +5% | +$1.04M | 0.37% | 85 |
|
|
2024
Q2 | $17.6M | Buy |
3,936,220
+756,383
| +24% | +$3.37M | 0.3% | 98 |
|
|
2024
Q1 | $24.4M | Hold |
3,179,837
| – | – | 0.38% | 80 |
|
|
2023
Q4 | $13.5M | Buy |
3,179,837
+54,837
| +2% | +$234K | 0.22% | 108 |
|
|
2023
Q3 | $13.1M | Buy |
+3,125,000
| New | +$13.1M | 0.24% | 108 |
|